Stanley Capital Management, LLC Bausch Health Companies Inc. Transaction History

Stanley Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $345,600 - $444,640	16,000 Added 7.8%	221,200 $5.05 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $658,320 - $784,800	24,000 Added 13.25%	205,200 $6.02 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $278,642 - $384,384	18,200 Added 11.17%	181,200 $3.77 Million
Q3 2020 Nov 16, 2020	SELL	$14.88 - $20.13 $2.43 Million - $3.28 Million	-163,000 Reduced 50.0%	163,000 $2.53 Million
Q3 2020 Nov 13, 2020	BUY	$14.88 - $20.13 $2.71 Million - $3.67 Million	182,200 Added 126.7%	326,000 $5.07 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $721,402 - $1.11 Million	-54,200 Reduced 27.37%	143,800 $2.63 Million
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $1.63 Million - $3.8 Million	-125,600 Reduced 38.81%	198,000 $3.07 Million
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $98,228 - $165,828	5,200 Added 1.63%	323,600 $9.68 Million
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $5.62 Million - $9.02 Million	318,400 New	318,400 $5.88 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.7B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Stanley Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stanley Capital Management, LLC with notifications on news.